Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL OMEGA 3 MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL OMEGA 3 MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 DEMAND AND SUPPLY-SIDE VARIABLES
2.2.8 CONSUMPTION TREND OF END PRODUCTS
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 STANDARDS OF MEASUREMENT
2.2.11 VENDOR SHARE ANALYSIS
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL OMEGA 3 MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 VALUE CHAIN ANALYSIS
5.2 SUPPLY CHAIN ANALYSIS
5.3 IMPORT-EXPORT ANALYSIS
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 BARGAINING POWER OF SUPPLIERS
5.4.2 BARGAINING POWER OF BUYERS/CONSUMERS
5.4.3 THREAT OF NEW ENTRANTS
5.4.4 THREAT OF SUBSTITUTE PRODUCTS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 RAW MATERIAL SOURCING ANALYSIS
5.6 OVERVIEW OF TECHNOLOGICAL INNOVATIONS
5.7 INDUSTRY TRENDS AND FUTURE PERSPECTIVE
5.8 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS
5.9 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS
6 IMPACT OF ECONOMIC SLOW DOWN ON MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON SUPPLY CHAIN
6.3 IMPACT ON SHIPMENT
6.4 IMPACT ON COMPANY’S STRATEGIC DECISIONS
7 REGULATORY FRAMEWORK AND GUIDELINES
8 PRICING INDEX (PRICE AT B2B END & PRICES AT FOB)
9 PRODUCTION CAPACITY OUTLOOK
10 BRAND OUTLOOK
10.1 COMPARATIVE BRAND ANALYSIS
10.2 PRODUCT VS BRAND OVERVIEW
11 GLOBAL OMEGA 3 MARKET, BY TYPE, 2018-2032 (USD MILLION) (TONS)
11.1 OVERVIEW
11.2 EICOSAPENTAENOIC ACID (EPA)
11.2.1 MARINE-BASED EPA
11.2.1.1. FISH OIL
11.2.1.2. KRILL OIL
11.2.2 PLANT-BASED EPA
11.2.2.1. ALGAE-BASED
11.2.2.2. SEED OIL-DERIVED
11.2.3 SYNTHETIC/BIOTECHNOLOGICALLY PRODUCED EPA
11.3 DOCOSAHEXAENOIC ACID (DHA)
11.3.1 MARINE-BASED DHA
11.3.1.1. FISH OIL
11.3.1.2. COD LIVER OIL
11.3.2 ALGAE-BASED DHA
11.3.2.1. PURE DHA
11.3.2.2. BLENDS (DHA + EPA)
11.3.3 SYNTHETIC/FERMENTED DHA
11.4 ARACHIDONIC ACID (ARA)
11.4.1 MICROBIAL FERMENTATION-DERIVED ARA
11.4.1.1. NATURAL ARA
11.4.1.2. MEAT-BASED
11.4.1.3. EGG-BASED
11.4.2 SYNTHETIC ARA
11.5 COMBINED EPA/DHA BLENDS
11.5.1 STANDARDIZED EPA/DHA BLENDS
11.5.2 CUSTOM BLENDS FOR SPECIFIC APPLICATIONS
11.6 ALPHA-LINOLENIC ACID (ALA)
11.7 STEARIDONIC ACID (SDA)
12 GLOBAL OMEGA 3 MARKET, BY SOURCE, 2018-2032 (USD MILLION)
12.1 OVERVIEW
12.2 PLANTS
12.2.1 ALGAE OIL
12.2.2 SEED-BASED OMEGA-3
12.2.2.1. FLAXSEED
12.2.2.2. CHIA SEED
12.2.2.3. CAMELINA SEED
12.2.3 NUT-BASED OMEGA-3
12.2.3.1. WALNUTS
12.2.3.2. PECANS
12.2.3.3. OTHERS
12.2.4 LEAFY GREENS
12.2.5 OTHERS
12.3 SEAFOODS
12.3.1 FISH OIL
12.3.1.1. ANCHOVY OIL
12.3.1.2. SALMON OIL
12.3.1.3. COD LIVER OIL
12.3.2 KRILL OIL
12.3.2.1. ANTARCTIC KRILL
12.3.2.2. SUPERCRITICAL EXTRACTION KRILL OIL
12.3.3 MARINE MICRO-ORGANISMS
12.3.3.1. SCHIZOCHYTRIUM
12.3.3.2. CRYPTHECODINIUM
12.3.3.3. OTHERS
12.3.4 OTHERS
12.4 BIOTECHNOLOGICALLY SYNTHESIZED OMEGA-3
12.4.1 FERMENTATION-BASED OMEGA-3
12.4.2 GENETICALLY ENGINEERED PLANTS OR ALGAE
12.5 ANIMAL-BASED OMEGA-3
12.5.1 DAIRY
12.5.2 EGGS
12.5.3 OTHERS
12.6 OTHERS
13 GLOBAL OMEGA 3 MARKET, BY FORM, 2018-2032 (USD MILLION)
13.1 OVERVIEW
13.2 OIL
13.3 POWDER
13.3.1 MICROCAPSULE POWDER
13.3.2 BIOMASS POWDER
13.4 OTHERS
14 GLOBAL OMEGA 3 MARKET, BY PRODUCTION METHOD, 2018-2032 (USD MILLION)
14.1 OVERVIEW
14.2 CULTIVATION OF MARINE MICROALGAE OR BACTERIA
14.3 PLANT MOLECULAR FARMING
14.4 PRECISION FERMENTATION
14.5 OTHERS
15 GLOBAL OMEGA 3 MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
15.1 OVERVIEW
15.2 DIETARY SUPPLEMENTS
15.2.1 DIETARY SUPPLEMENTS, BY TYPE
15.2.1.1. EICOSAPENTAENOIC ACID (EPA)
15.2.1.2. DOCOSAHEXAENOIC ACID (DHA)
15.2.1.3. ARACHIDONIC ACID (ARA)
15.2.1.4. COMBINED EPA/DHA BLENDS
15.2.1.5. ALPHA-LINOLENIC ACID (ALA)
15.2.1.6. STEARIDONIC ACID (SDA)
15.2.2 DIETARY SUPPLEMENTS, BY CATEGORY
15.2.2.1. CHEWABLES & GUMMIES
15.2.2.2. CAPSULES
15.2.2.3. POWDERS
15.2.2.4. TABLETS & SOFTGELS
15.2.2.5. OTHERS
15.2.3 DIETARY SUPPLEMENTS, BY TARGET CONSUMER
15.2.3.1. SPORTS FITNESS
15.2.3.2. ENERGY & WEIGHT MANAGEMENT
15.2.3.3. GENERAL HEALTH
15.2.3.4. BONE & JOINT HEALTH
15.2.3.5. GASTROINTESTINAL HEALTH
15.2.3.6. IMMUNITY
15.2.3.7. CARDIAC HEALTH
15.2.3.8. DIABETES
15.2.3.9. ANTI-CANCER
15.2.3.10. SKIN/HAIR/NAILS
15.2.3.11. BRAIN/MENTAL HEALTH
15.2.3.12. OTHERS
15.3 FUNCTIONAL FOODS AND BEVERAGES
15.3.1 FUNCTIONAL FOODS AND BEVERAGES, BY TYPE
15.3.1.1. EICOSAPENTAENOIC ACID (EPA)
15.3.1.2. DOCOSAHEXAENOIC ACID (DHA)
15.3.1.3. ARACHIDONIC ACID (ARA)
15.3.1.4. COMBINED EPA/DHA BLENDS
15.3.1.5. ALPHA-LINOLENIC ACID (ALA)
15.3.1.6. STEARIDONIC ACID (SDA)
15.3.2 FUNCTIONAL FOODS AND BEVERAGES, BY PRODUCT TYPE
15.3.2.1. OMEGA-3 ENRICHED DAIRY
15.3.2.1.1. MILK AND YOGURT
15.3.2.1.2. BUTTER AND CHEESE SPREADS
15.3.2.1.3. OTHERS
15.3.2.2. FORTIFIED BEVERAGES
15.3.2.2.1. JUICES
15.3.2.2.2. SMOOTHIES AND SHAKES
15.3.2.2.3. OTHERS
15.3.2.3. OMEGA-3 INFUSED SNACKS
15.3.2.3.1. PROTEIN BARS
15.3.2.3.2. CHIPS
15.3.2.3.3. OTHERS
15.3.2.4. OMEGA-3 FORTIFIED CEREALS AND GRAINS
15.4 SKINCARE AND PERSONAL CARE
15.4.1 SKINCARE AND PERSONAL CARE, BY TYPE
15.4.1.1. EICOSAPENTAENOIC ACID (EPA)
15.4.1.2. DOCOSAHEXAENOIC ACID (DHA)
15.4.1.3. ARACHIDONIC ACID (ARA)
15.4.1.4. COMBINED EPA/DHA BLENDS
15.4.1.5. ALPHA-LINOLENIC ACID (ALA)
15.4.1.6. STEARIDONIC ACID (SDA)
15.4.2 SKINCARE AND PERSONAL CARE, BY PRODUCT TYPE
15.4.2.1. SKIN CARE
15.4.2.1.1. SUN SCREEN LOTION
15.4.2.1.2. SERUM
15.4.2.1.3. MOISTURIZER
15.4.2.1.4. SCRUB
15.4.2.1.5. LIP CARE CREAM
15.4.2.1.6. OTHERS
15.4.2.2. HAIR CARE
15.4.2.2.1. SHAMPOO
15.4.2.2.2. CONDITIONER
15.4.2.2.3. HAIR OIL AND SERUM
15.4.2.2.4. OTHERS
15.4.2.3. OTHERS
15.5 PHARMACEUTICALS
15.5.1 PHARMACEUTICALS, BY TYPE
15.5.1.1. EICOSAPENTAENOIC ACID (EPA)
15.5.1.2. DOCOSAHEXAENOIC ACID (DHA)
15.5.1.3. ARACHIDONIC ACID (ARA)
15.5.1.4. COMBINED EPA/DHA BLENDS
15.5.1.5. ALPHA-LINOLENIC ACID (ALA)
15.5.1.6. STEARIDONIC ACID (SDA)
15.5.2 PHARMACEUTICALS, BY PRODUCT TYPE
15.5.2.1. PRESCRIPTION OMEGA-3 DRUGS
15.5.2.2. CARDIOVASCULAR HEALTH SUPPLEMENTS
15.5.2.3. NEUROLOGICAL AND COGNITIVE HEALTH TREATMENTS
15.5.2.4. ANTI-INFLAMMATORY FORMULATIONS
15.5.2.5. OTHERS
15.6 INFANT FORMULAS
15.6.1 INFABT FORMULAS, BY TYPE
15.6.1.1. EICOSAPENTAENOIC ACID (EPA)
15.6.1.2. DOCOSAHEXAENOIC ACID (DHA)
15.6.1.3. ARACHIDONIC ACID (ARA)
15.6.1.4. COMBINED EPA/DHA BLENDS
15.6.1.5. ALPHA-LINOLENIC ACID (ALA)
15.6.1.6. STEARIDONIC ACID (SDA)
15.6.2 INFANT FORMULAS, BY STAGE
15.6.2.1. SATGE 1
15.6.2.2. STAGE 2
15.6.2.3. STAGE 3
15.6.2.4. STAGE 4
15.6.3 INFANT FORMAULAS, BY FORMULA TYPE
15.6.3.1. STANDARD DHA/ARA FORTIFIED FORMULAS
15.6.3.2. HYPOALLERGENIC OR SPECIALIZED MEDICAL FORMULAS
15.6.4 OTHERS
15.7 ANIMAL NUTRITION
15.7.1 ANIMAL NUTRITION, BY TYPE
15.7.1.1. EICOSAPENTAENOIC ACID (EPA)
15.7.1.2. DOCOSAHEXAENOIC ACID (DHA)
15.7.1.3. ARACHIDONIC ACID (ARA)
15.7.1.4. COMBINED EPA/DHA BLENDS
15.7.1.5. ALPHA-LINOLENIC ACID (ALA)
15.7.1.6. STEARIDONIC ACID (SDA)
15.7.2 ANIMAL NUTRITION, BY END-USE
15.7.2.1. RUMINANTS
15.7.2.1.1. CALVES
15.7.2.1.2. DAIRY CATTLE
15.7.2.1.3. BEEF CATTLE
15.7.2.2. POULTRY
15.7.2.2.1. BROILER
15.7.2.2.2. LAYERS
15.7.2.2.3. BREEDER
15.7.2.3. SWINE
15.7.2.3.1. STARTERS
15.7.2.3.2. GROWERS
15.7.2.3.3. OTHERS
15.7.2.4. PET
15.7.2.4.1. CAT
15.7.2.4.2. DOG
15.7.2.4.3. RABBIT
15.7.2.4.4. MICE
15.7.2.4.5. OTHERS
15.7.2.5. AQUATIC ANIMAL
15.7.2.5.1. FISH FEED
15.7.2.5.2. MOLLUSK FEED
15.7.2.5.3. CRUSTACEANS
15.7.2.5.4. OTHERS
15.8 MEDICAL FOODS
15.8.1 MEDCIAL FOODS, BY TYPE
15.8.1.1. EICOSAPENTAENOIC ACID (EPA)
15.8.1.2. DOCOSAHEXAENOIC ACID (DHA)
15.8.1.3. ARACHIDONIC ACID (ARA)
15.8.1.4. COMBINED EPA/DHA BLENDS
15.8.1.5. ALPHA-LINOLENIC ACID (ALA)
15.8.1.6. STEARIDONIC ACID (SDA)
15.8.2 MEDICAL FOODS, BY END-USE
15.8.2.1. THERAPEUTIC NUTRITION FOR CHRONIC DISEASES
15.8.2.2. OMEGA-3 FOR MALNOURISHMENT RECOVERY
15.8.3 OTHERS
15.9 OTHERS
16 GLOBAL OMEGA 3 MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: GLOBAL
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
16.3 COMPANY SHARE ANALYSIS: EUROPE
16.4 COMPANY SHARE ANALYSIS: ASIAP-PACIFIC
16.5 MERGERS & ACQUISITIONS
16.6 NEW PRODUCT DEVELOPMENT & APPROVALS
16.7 EXPANSIONS & PARTNERSHIP
16.8 REGULATORY CHANGES
17 GLOBAL OMEGA 3 MARKET, BY GEOGRAPHY, 2018-2032 (USD MILLION) (TONS)
17.1 OVERVIEW (ALL SEGMENTATION PROVIDED ABOVE IS REPRESNTED IN THIS CHAPTER BY COUNTRY)
17.2 NORTH AMERICA
17.2.1 U.S.
17.2.2 CANADA
17.2.3 MEXICO
17.3 EUROPE
17.3.1 GERMANY
17.3.2 U.K.
17.3.3 ITALY
17.3.4 FRANCE
17.3.5 SPAIN
17.3.6 RUSSIA
17.3.7 SWITZERLAND
17.3.8 TURKEY
17.3.9 BELGIUM
17.3.10 POLAND
17.3.11 DENMARK
17.3.12 NORWAY
17.3.13 SWEDEN
17.3.14 NETHERLANDS
17.3.15 REST OF EUROPE
17.4 ASIA-PACIFIC
17.4.1 JAPAN
17.4.2 CHINA
17.4.3 SOUTH KOREA
17.4.4 INDIA
17.4.5 SINGAPORE
17.4.6 THAILAND
17.4.7 INDONESIA
17.4.8 MALAYSIA
17.4.9 PHILIPPINES
17.4.10 AUSTRALIA
17.4.11 NEW ZEALAND
17.4.12 REST OF ASIA-PACIFIC
17.5 SOUTH AMERICA
17.5.1 BRAZIL
17.5.2 ARGENTINA
17.5.3 REST OF SOUTH AMERICA
17.6 MIDDLE EAST AND AFRICA
17.6.1 SOUTH AFRICA
17.6.2 EGYPT
17.6.3 SAUDI ARABIA
17.6.4 UNITED ARAB EMIRATES
17.6.5 ISRAEL
17.6.6 REST OF MIDDLE EAST AND AFRICA
18 GLOBAL OMEGA 3 MARKET, SWOT & DBMR ANALYSIS
19 GLOBAL OMEGA 3 MARKET, COMPANY PROFILE
19.1 BASF
19.1.1 COMPANY OVERVIEW
19.1.2 REVENUE ANALYSIS
19.1.3 PRODUCT PORTFOLIO
19.1.4 RECENT DEVELOPMENTS
19.2 DSM-FIRMENICH
19.2.1 COMPANY OVERVIEW
19.2.2 REVENUE ANALYSIS
19.2.3 PRODUCT PORTFOLIO
19.2.4 RECENT DEVELOPMENTS
19.3 CRODA INTERNATIONAL PLC
19.3.1 COMPANY OVERVIEW
19.3.2 REVENUE ANALYSIS
19.3.3 PRODUCT PORTFOLIO
19.3.4 RECENT DEVELOPMENTS
19.4 CORBION
19.4.1 COMPANY OVERVIEW
19.4.2 REVENUE ANALYSIS
19.4.3 PRODUCT PORTFOLIO
19.4.4 RECENT DEVELOPMENTS
19.5 ARISTA INDUSTRIES, INC.
19.5.1 COMPANY OVERVIEW
19.5.2 REVENUE ANALYSIS
19.5.3 PRODUCT PORTFOLIO
19.5.4 RECENT DEVELOPMENTS
19.6 NU-MEGA INGREDIENTS
19.6.1 COMPANY OVERVIEW
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 OMEGA PROTEIN CORPORATION
19.7.1 COMPANY OVERVIEW
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT DEVELOPMENTS
19.8 COPEINCA SAC
19.8.1 COMPANY OVERVIEW
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENTS
19.9 EPAX
19.9.1 COMPANY OVERVIEW
19.9.2 REVENUE ANALYSIS
19.9.3 PRODUCT PORTFOLIO
19.9.4 RECENT DEVELOPMENTS
19.1 SOLUTEX
19.10.1 COMPANY OVERVIEW
19.10.2 REVENUE ANALYSIS
19.10.3 PRODUCT PORTFOLIO
19.10.4 RECENT DEVELOPMENTS
19.11 OLVEA OMEGA SOLUTIONS
19.11.1 COMPANY OVERVIEW
19.11.2 REVENUE ANALYSIS
19.11.3 PRODUCT PORTFOLIO
19.11.4 RECENT DEVELOPMENTS
19.12 GOLDEN OMEGA
19.12.1 COMPANY OVERVIEW
19.12.2 REVENUE ANALYSIS
19.12.3 PRODUCT PORTFOLIO
19.12.4 RECENT DEVELOPMENTS
19.13 KINOMEGA BIOPHARM INC
19.13.1 COMPANY OVERVIEW
19.13.2 REVENUE ANALYSIS
19.13.3 PRODUCT PORTFOLIO
19.13.4 RECENT DEVELOPMENTS
19.14 GC RIEBER VIVOMEGA AS
19.14.1 COMPANY OVERVIEW
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT DEVELOPMENTS
19.15 EVONIK INDUSTRIES AG
19.15.1 COMPANY OVERVIEW
19.15.2 REVENUE ANALYSIS
19.15.3 PRODUCT PORTFOLIO
19.15.4 RECENT DEVELOPMENTS
19.16 IMPERIAL-OEL-IMPORT HANDELSGESELLSCHAFT MBH
19.16.1 COMPANY OVERVIEW
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENTS
19.17 ALPSPURE LIFESCIENCES PVT. LTD.
19.17.1 COMPANY OVERVIEW
19.17.2 REVENUE ANALYSIS
19.17.3 PRODUCT PORTFOLIO
19.17.4 RECENT DEVELOPMENTS
19.18 PHYTOLOGIX LIFE SCIENCES
19.18.1 COMPANY OVERVIEW
19.18.2 REVENUE ANALYSIS
19.18.3 PRODUCT PORTFOLIO
19.18.4 RECENT DEVELOPMENTS
19.19 ELEMENTA
19.19.1 COMPANY OVERVIEW
19.19.2 REVENUE ANALYSIS
19.19.3 PRODUCT PORTFOLIO
19.19.4 RECENT DEVELOPMENTS
19.2 KD PHARMA GROUP SA
19.20.1 COMPANY OVERVIEW
19.20.2 REVENUE ANALYSIS
19.20.3 PRODUCT PORTFOLIO
19.20.4 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
20 RELATED REPORTS
21 QUESTIONNAIRE
22 ABOUT DATA BRIDGE MARKET RESEARCH
